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ABSTRACT
Infectious disease outbreaks are a threat to global health and security. Current systems for 
early and effective reporting and monitoring of pathogens and other health threats, and 
high-quality surveillance of human diseases, face a number of challenges including incom-
plete and fragmented early warning and governance systems that are under-incentivised 
and under-resourced. We propose a number of opportunities for the G20 leaders to address 
these challenges, including: (1) establishing an ‘Emerging Health Threat Data Platform’ as a 
public good for independent, co-ordinated and scientist-led reporting and surveillance of 
pathogens; (2) supporting the development of a framework to incentivise scientists to par-
ticipate in the platform and; (3) enhancing population health surveillance and vital registra-
tion systems through technical and financial investments in both the short and longer term.
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CHALLENGE
As a global society we face the likelihood of infectious disease outbreaks occurring more 
frequently (Smith et al., 2014). We are at risk of increased zoonotic (animal to human) expo-
sure including through a combination of habitat destruction and the climate crisis. Further-
more, demographic shifts resulting in more people living in high population density urban 
environments, and industrialized farming systems that result in the emergence of antibi-
otic resistance, are likely to lead to more frequent outbreaks of new, emerging or known 
(but resistant) pathogens. Addressing the growing threat of infectious disease outbreaks 
requires pathogen and disease reporting and surveillance systems that are fit for purpose 
– they need to both act as an early warning system for impending threats to human health 
(accurately, efficiently and effectively, e.g. by ensuring coverage is both widespread and suf-
ficiently granular to identify groups at increased risk in a population) and to monitor an out-
break once established, applying a One Health approach.1
Early warning systems for emerging outbreaks are crucial in promoting timely implementa-
tion of public policy measures that can avert deaths, reduce onward transmission and result 
in overall lower levels of social, economic and political fallout (O’Kell et al., 2020). The second 
report on progress of the Independent Panel for Pandemic Preparedness and Response 
reviewing early COVID-19 measures noted “there was potential for early signs to have been 
acted on more rapidly, with an escalation of response tied more immediately to the emerg-
ing information about the spread of the virus” and reflected that by missing this opportunity 
for early action on signs of an outbreak, this resulted in “lost opportunities to apply basic 
public health measures at the earliest opportunity” (Independent Panel, 2021).
Globally, reporting of outbreaks is governed by the International Health Regulations (IHR) of 
2005 (World Health Assembly, 2005) which are recognized as a means of international co-
operation for early detection and containment of infectious diseases. Adopted by all World 
Health Organization (WHO) member states, they are legally binding, The IHR also permit 
non-state actors to report suspected outbreaks directly to WHO. However, the non-state 
monitoring of potential outbreaks is often not of significant value even if it forms a relevant 
proportion of all reports to WHO, because most of it is centred on “digital disease detection” 
which includes social media and website scanning, as well as monitoring of big data and 
may run the risk of “false alarms” unless clear and consistent filters and criteria are applied 
to the results. 
The COVID-19 pandemic has shown that existing reporting and surveillance systems exhibit 
a number of weaknesses, including:
1) comprehensive early warning systems of pathogens are incomplete and fragmented 
and therefore slow to respond to outbreaks; in addition, they do not include voluntary 
and independent reporting by experts; 
2) once an outbreak is established, epidemiological surveillance systems are often of low 
capacity and are insufficiently granular (disaggregated) to identify places and popula-
tions requiring enhanced resources for effective and equitable control interventions; 
and 
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3) governance systems for surveillance for both pathogens and people are politicized, 
under-incentivised and under-resourced. 
The transparent and timely reporting of potential outbreaks by scientists, in both the pub-
lic and private sectors, is currently not realizing its full potential for two main reasons: (1) in 
some settings scientists may be operating within systems where their capacity for prompt, 
independent and transparent reporting is curtailed; and (2) career structures and incentives 
for scientists usually focus on the model of peer-reviewed publishing rather than collabo-
rative information-sharing – which means that delays to and disincentives for data sharing, 
data accessibility and early reporting are present. 
Once an epidemic or pandemic is officially declared, a more efficient and transparent sys-
tem of epidemiological monitoring and surveillance of human population would enable 
countries to identify communities vulnerable to infection, enhance evaluation of the im-
pact of intervention measures, increase the effectiveness and equity of public health control 
strategies, while the added transparency could reduce ‘infodemics’ on social media and 
reassure both domestic and international publics.
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PROPOSAL
G20 countries employ almost 90% of the world’s researchers (Editage, 2019) and account for 
over 90% of global R&D expenditure (UNESCO, 2016; OECD/UNDP, n.d.). As a result, the G20 
is well positioned to lead in advancing innovative solutions for future pandemic control. This 
policy brief makes several proposals in that regard. The brief covers activities undertaken in 
both the public and private sectors – the latter is acknowledged to play a significant (and 
growing) role in data generation and management, including in relation to disease out-
breaks.
INDEPENDENT, CO-ORDINATED, SCIENTIST-LED MONITORING 
OF EMERGING HEALTH THREATS 
Independent, incentivised and scientist-led reporting and monitoring of pathogens and 
other emerging health threats would enable researchers to share information in a peer-to-
peer network, free of the political constraints inherent in the current reporting systems. 
We propose the following mechanisms to enhance early warning systems: 
Establish an ‘Emerging Health Threat Data Platform’ as a public good for scientist-led 
reporting on new and emerging pathogens, treatment-resistant pathogens, or any other 
element that could cause a public health emergency, following a One Health integrated 
approach.
Participation in such a global platform would enable the scientific community to be rapid 
and flexible in sharing information and would also enhance scientists’ access to information 
needed to study emerging/novel pathogens, and initiate risk assessments. The platform 
would be open to publicly funded scientists. Inputs from scientists working in the private 
sector should be included, subject to the necessary assurances of independence. Partic-
ipation for all scientists would be voluntary, and subject to strict criteria of standards and 
formats to ensure validity and quality of data as well as independence and respect of confi-
dentiality. Scientists in both the public and private sectors should be incentivised to contrib-
ute to the platform – benefits of participation could include measures that attribute the in-
tellectual contribution of scientists, including through recognition of overall societal impact. 
The One Health integrated approach will ensure consideration of all alerts arising at the 
human-animal and environment interface and cover alerts arising in animal populations or 
food sources, which could impact on human health.
In order to mitigate risk of information overload and to promote data quality, the platform 
should be equipped with digital tools drawn from artificial intelligence in order to efficiently 
manage, verify and respond appropriately to data received. 
The platform would require resources and a structure, such as a centralized secretariat, gov-
erned by scientists and independent of any national interest, in order to ensure accessibility 
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by all scientists worldwide. The secretariat would seek diversified funding so as to promote 
and retain independence and ensure access and sharing of data. Additionally, the secretari-
at would foster links to the appropriate global agency charged with the authority to investi-
gate and respond to suspected outbreaks.
Support the engagement of publicly financed scientists and institutions in the global 
platform to facilitate their access to high-quality data. Support should include the provi-
sion of incentives along with regulations to encourage their participation. This would ensure: 
(i) timely sharing of newly produced data; (ii) timely quality control and validation of data 
(NASEM, 2018); and (iii) ease of access for scientists to use other scientists’ data (Wilkinson et 
al., 2016). Collectively these can be considered as a “data as a global good” system. 
This system would include: (i) adjustments of the principles of the career promotion of pub-
licly funded scientists (Royal Society, 2020), so as to put more emphasis on the societal im-
pact of research activities and less emphasis on formal publication metrics (Royal Society, 
n.d.); this includes incentives for researchers to make data accessible; (ii) enhanced stand-
ards for data validation, harmonization and reproducibility; and (iii) a system of fast and in-
clusive peer review (Vesper, 2018).
Many governments were able to enter into arrangements with the private sector in order to 
access data held by the private sector that were essential to track and trace systems. The 
private sector has additional data that is currently not readily accessible to the wider public-
ly funded scientific community. New incentives and arrangements are needed to facilitate 
collaboration between scientists in the public and private sectors (ICC, 2020). Specifically, 
governments should investigate additional incentives and arrangements so that the com-
mercial sector shares data that could be useful for research that informs policy responses to 
a rapidly evolving pandemic. 
The need to strengthen and adequately resource surveillance on potential outbreaks, in-
cluding rapid and transparent cross-sectoral information and data sharing at international 
level has been highlighted both in the Rome Declaration of the Global Health Summit (EU, 
2019) and in the G7 Carbis Bay Declaration (G7, 2021), so as to ensure effective surveillance of 
pathogens based on the One Health approach. In addition, the WHO has committed to the 
establishment of a new Hub for Pandemic and Epidemic Intelligence which, through new 
collaborations of countries and partners, will use innovative tools and approaches in order to 
increase both availability and linkage of data, and develop predictive models for risk analysis. 
The WHO has declared that this new hub will accelerate global collaborations across public 
and private sector organizations, academia and international partner networks (WHO, 2021).
The new Emerging Health Threat Data platform which is proposed in this policy paper 
would be one of the networks that feed into the new WHO Hub. By leveraging the vast set 
of data, information and analytics produced through the independent collaboration of the 
global community of scientists, the proposed platform would directly contribute to the mis-
sion of the new WHO Hub.
Enhanced, co-ordinated population health surveillance and vital registration systems. 
High-quality population health data lies at the core of both effective and equitable respons-
es to public health emergencies; it is central to designing evidence-informed policy-making 
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and to guiding and evaluating targeted interventions that are likely to have maximum effect 
in mitigating the impacts of a pandemic or epidemic. Despite repeated calls for data that 
is fit for purpose, and in line with the commitment of Sustainable Development Goal 17.18 
(UN, 2017) for data that is disaggregated and relevant in national contexts, the COVID-19 
pandemic has highlighted the weaknesses of many health and vital registration systems. 
WHO guidelines (WHO, 2020) on public health surveillance of COVID-19 call on countries to 
report data disaggregated, at a minimum, by age and sex. However, over the course of the 
pandemic surveillance data has been reported inconsistently and often in an ad hoc man-
ner, and data quality (including whether or not it is disaggregated) remains problematic. 
For example, in the first 12 months of the pandemic, approximately 20% of all, and 30% of 
all cases, were reported without any indication of whether they referred to men or women 
(Sex, Gender and COVID-19 Project, 2020), moreover, the proportion of countries reporting 
sex-disaggregated data appears to be falling (Sex, Gender and COVID-19 Project, 2021). Low- 
and lower-middle-income are less likely to report disaggregated data than high-income 
countries (Hawkes et al, 2021). However, even among the G20 countries, several have either 
never or only infrequently and inconsistently reported sex-disaggregated data on COVID-19. 
Such findings are disappointing given the urgency in accessing accurate data in a pan-
demic, and they are compounded by the existing weaknesses of both disease surveillance 
and vital registration systems. It is estimated, for example, that only around one third all of 
deaths in Africa are registered (UNECA, 2017), and inequalities remain even in death with 
higher registration rates for men compared to women, and for urban compared with rural 
populations, in some countries (CVRS, 2019). Improving surveillance during a pandemic is 
possible but requires an investment in pre-existing (but currently weak) vital registration 
systems and the creation of robust and resilient data infrastructures. 
Public health surveillance systems for reporting disaggregated data exist and can be rep-
licated during pandemics and epidemics. For example, for established epidemics such as 
HIV, a global monitoring system headed by UNAIDS, and mandated through the 2016 Unit-
ed Nations Political Declaration on Ending AIDS (UNAIDS, 2020), collects relevant, harmo-
nized and disaggregated data on progress towards global targets. Meanwhile, the COVID-19 
pandemic has been characterized by the establishment of independent monitoring sys-
tems (Johns Hopkins University Coronavirus Resource Center, 2020; Our World in Data, 2021; 
Sex, Gender and COVID-19 Project, 2020) that have responded to the gaps in global systems 
and regularly published data on, for example, sex-and age-disaggregated cases and deaths. 
We propose the following actions:
ظ  Increase technical and financial investments to enhance population surveillance dur-
ing public health emergencies;
ظ  In the context of the IHR, countries to be supported and encouraged to report health 
emergency data to WHO in a standardized, disaggregated manner (including age and 
sex), with additional nationally relevant disaggregation as appropriate to each country; 
and 
ظ  Support – financial, technical – both public health surveillance and vital registration 
systems in low- and lower-middle income countries over the longer term. 
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ROLE OF G20 IN SUPPORTING GLOBAL HEALTH THROUGH 
STRONGER INDEPENDENT MONITORING OF EMERGING 
HEALTH THREATS AND ENHANCED POPULATION HEALTH 
SURVEILLANCE 
We call on G20 leaders at the Italy Summit “People, Planet and Prosperity” on 30–31 October 
2021 to make specific, measurable and time-bound commitments in three areas to support 
rapid alert and health population surveillance efforts to mitigate the impact of future pan-
demics on health, society, economy and environment, in particular by:
ظ  Supporting the establishment of a science-led emerging health threat reporting and 
monitoring platform, called ‘Emerging Health Threat Data Platform’. This will include 
resources for the establishment of a new Data Platform on emerging health threats 
as a public good, based on improved networking of scientists and a more efficient ex-
change and assessment of information on potential risks, following a One Health inte-
grated approach. This platform should be scientist-led and subject to strict guidance 
and regulations covering quality, independence and confidentiality. 
ظ  Coordinating and supporting the development of a framework of incentives for re-
searchers to make data accessible and commit to piloting this framework in G20 
countries. This will require a broad consultative process that includes representatives 
of national bodies governing science, funders, publishers, the commercial sector, sci-
entists and other relevant stakeholders.
ظ  Ensuring reporting of harmonized and disaggregated surveillance for people and 
populations globally, including through:
- modelling good practices for sex-and age-disaggregated reporting, including for 
vaccine coverage at national level in G20 countries; 
- supporting the strengthening of capacity in lower-resourced countries to report 
disaggregated data from existing civil registration and vital statistics programmes 
as well as from health system surveillance programmes, and encourage all coun-
tries to report such disaggregated data to WHO (health data) and UN statistical 
bodies (vital statistics);
- providing additional support to WHO for collating, reporting and publishing disag-
gregated data.
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NOTES
1 ‘One Health is a collaborative, multisectoral, and transdisciplinary approach — working at 
the local, regional, national, and global levels — with the goal of achieving optimal health 
outcomes recognizing the interconnection between people, animals, plants, and their 
shared environment’ (https://www.cdc.gov/onehealth/basics/index.html).
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